PaHa02g25710.1

Functional evidence

Functional index matched identifier: PaHa02g25710

eggNOG

Preferred name: LOC103720177 | Seed ortholog: 337451.A0A443N577 | COG: COG0459 | eggNOG OG: Cpn60_TCP1@131567|Dy-13, Cpn60_TCP1@33090|QFu-55

Gene Ontology

GO:0000325 plant-type vacuole; GO:0001530 lipopolysaccharide binding; GO:0001666 response to hypoxia; GO:0002039 p53 binding; GO:0002119 nematode larval development; GO:0002755 MyD88-dependent toll-like receptor signaling pathway; GO:0002842 positive regulation of T cell mediated immune response to tumor cell; GO:0002931 response to ischemia; GO:0003688 DNA replication origin binding; GO:0003697 single-stranded DNA binding; GO:0003723 RNA binding; GO:0003725 double-stranded RNA binding; GO:0005515 protein binding; GO:0005739 mitochondrion; GO:0005829 cytosol; GO:0006457 protein folding; GO:0006458 'de novo' protein folding; GO:0006915 apoptotic process; GO:0006986 response to unfolded protein; GO:0007005 mitochondrion organization; GO:0007283 spermatogenesis; GO:0007301 female germline ring canal formation; GO:0007424 open tracheal system development; GO:0008035 high-density lipoprotein particle binding; GO:0008637 apoptotic mitochondrial changes; GO:0009408 response to heat; GO:0009409 response to cold; GO:0009410 response to xenobiotic stimulus; GO:0009507 chloroplast; GO:0009792 embryo development ending in birth or egg hatching; GO:0010506 regulation of autophagy; GO:0010821 regulation of mitochondrion organization; GO:0014003 oligodendrocyte development; GO:0014823 response to activity; GO:0016887 ATP hydrolysis activity; GO:0019216 regulation of lipid metabolic process; GO:0019899 enzyme binding; GO:0019954 asexual reproduction; GO:0030150 protein import into mitochondrial matrix; GO:0030707 follicle cell of egg chamber development; GO:0031101 fin regeneration; GO:0031288 sorocarp morphogenesis; GO:0031625 ubiquitin protein ligase binding; GO:0032496 response to lipopolysaccharide; GO:0032727 positive regulation of interferon-alpha production; GO:0032729 positive regulation of type II interferon production; GO:0032733 positive regulation of interleukin-10 production; GO:0032735 positive regulation of interleukin-12 production; GO:0032755 positive regulation of interleukin-6 production; GO:0032760 positive regulation of tumor necrosis factor production; GO:0033198 response to ATP; GO:0034185 apolipoprotein binding; GO:0034186 apolipoprotein A-I binding; GO:0034514 mitochondrial unfolded protein response; GO:0034605 cellular response to heat; GO:0042026 protein refolding; GO:0042100 B cell proliferation; GO:0042110 T cell activation; GO:0042113 B cell activation; GO:0042127 regulation of cell population proliferation; GO:0042220 response to cocaine; GO:0042246 tissue regeneration; GO:0042542 response to hydrogen peroxide; GO:0042742 defense response to bacterium; GO:0043032 positive regulation of macrophage activation; GO:0043066 negative regulation of apoptotic process; GO:0043524 negative regulation of neuron apoptotic process; GO:0043627 response to estrogen; GO:0044183 protein folding chaperone; GO:0044877 protein-containing complex binding; GO:0045041 protein import into mitochondrial intermembrane space; GO:0046956 positive phototaxis; GO:0048291 isotype switching to IgG isotypes; GO:0048477 oogenesis; GO:0050821 protein stabilization; GO:0050870 positive regulation of T cell activation; GO:0051087 protein-folding chaperone binding; GO:0051131 chaperone-mediated protein complex assembly; GO:0051384 response to glucocorticoid; GO:0051604 protein maturation; GO:0051702 biological process involved in interaction with symbiont; GO:0060297 regulation of sarcomere organization; GO:0061629 RNA polymerase II-specific DNA-binding transcription factor binding; GO:0071470 cellular response to osmotic stress; GO:0071502 cellular response to temperature stimulus; GO:0071866 negative regulation of apoptotic process in bone marrow cell; GO:0090022 regulation of neutrophil chemotaxis; GO:0098761 cellular response to interleukin-7; GO:0140030 modification-dependent protein binding; GO:0140608 cysteine-type endopeptidase activator activity; GO:1900118 negative regulation of execution phase of apoptosis; GO:1900119 positive regulation of execution phase of apoptosis; GO:1903427 negative regulation of reactive oxygen species biosynthetic process; GO:1903779 regulation of cardiac conduction; GO:1904638 response to resveratrol

KEGG

EC: ec:5.6.1.7 | KO: K04077 | Pathway: 03018 | BRITE: 00001, 01000, 03019, 03029, 03110, 04147